OBJECTIVE: Optimal US screening strategies remain controversial. We use six simulation models to evaluate screening outcomes under varying strategies. METHODS: The models incorporate common data on incidence, mammography characteristics, and treatment effects. We evaluate varying initiation and cessation ages applied annually or biennially and calculate mammograms, mortality reduction (vs. no screening), false-positives, unnecessary biopsies and over-diagnosis. RESULTS: The lifetime risk of breast cancer death starting at age 40 is 3% and is reduced by screening. Screening biennially maintains 81% (range 67% to 99%) of annual screening benefits with fewer false-positives. Biennial screening from 50-74 reduces the probability of breast cancer death from 3% to 2.3%. Screening annually from 40 to 84 only lowers mortality an additional one-half of one percent to 1.8% but requires substantially more mammograms and yields more false-positives and over-diagnosed cases. CONCLUSION: Decisions about screening strategy depend on preferences for benefits vs. potential harms and resource considerations.
OBJECTIVE: Optimal US screening strategies remain controversial. We use six simulation models to evaluate screening outcomes under varying strategies. METHODS: The models incorporate common data on incidence, mammography characteristics, and treatment effects. We evaluate varying initiation and cessation ages applied annually or biennially and calculate mammograms, mortality reduction (vs. no screening), false-positives, unnecessary biopsies and over-diagnosis. RESULTS: The lifetime risk of breast cancer death starting at age 40 is 3% and is reduced by screening. Screening biennially maintains 81% (range 67% to 99%) of annual screening benefits with fewer false-positives. Biennial screening from 50-74 reduces the probability of breast cancer death from 3% to 2.3%. Screening annually from 40 to 84 only lowers mortality an additional one-half of one percent to 1.8% but requires substantially more mammograms and yields more false-positives and over-diagnosed cases. CONCLUSION: Decisions about screening strategy depend on preferences for benefits vs. potential harms and resource considerations.
Authors: L Tabár; B Vitak; H H Chen; S W Duffy; M F Yen; C F Chiang; U B Krusemo; T Tot; R A Smith Journal: Radiol Clin North Am Date: 2000-07 Impact factor: 2.303
Authors: Robert D Rosenberg; Bonnie C Yankaskas; Linn A Abraham; Edward A Sickles; Constance D Lehman; Berta M Geller; Patricia A Carney; Karla Kerlikowske; Diana S M Buist; Donald L Weaver; William E Barlow; Rachel Ballard-Barbash Journal: Radiology Date: 2006-10 Impact factor: 11.105
Authors: Lennarth Nyström; Ingvar Andersson; Nils Bjurstam; Jan Frisell; Bo Nordenskjöld; Lars Erik Rutqvist Journal: Lancet Date: 2002-03-16 Impact factor: 79.321
Authors: Donald A Berry; Kathleen A Cronin; Sylvia K Plevritis; Dennis G Fryback; Lauren Clarke; Marvin Zelen; Jeanne S Mandelblatt; Andrei Y Yakovlev; J Dik F Habbema; Eric J Feuer Journal: N Engl J Med Date: 2005-10-27 Impact factor: 91.245
Authors: Jacques Fracheboud; Johanna Helëne Groenewoud; Rob Boer; Gerrit Draisma; Arry E de Bruijn; André L M Verbeek; Harry J de Koning Journal: Int J Cancer Date: 2006-04-15 Impact factor: 7.396
Authors: Jeanne S Mandelblatt; Kathleen A Cronin; Stephanie Bailey; Donald A Berry; Harry J de Koning; Gerrit Draisma; Hui Huang; Sandra J Lee; Mark Munsell; Sylvia K Plevritis; Peter Ravdin; Clyde B Schechter; Bronislava Sigal; Michael A Stoto; Natasha K Stout; Nicolien T van Ravesteyn; John Venier; Marvin Zelen; Eric J Feuer Journal: Ann Intern Med Date: 2009-11-17 Impact factor: 25.391
Authors: Jeanne S Mandelblatt; Clyde B Schechter; K Robin Yabroff; William Lawrence; James Dignam; Martine Extermann; Sarah Fox; Gretchen Orosz; Rebecca Silliman; Jennifer Cullen; Lodovico Balducci Journal: J Gen Intern Med Date: 2005-06 Impact factor: 5.128
Authors: J P Kepros; R C Opreanu; R Samaraweera; A Briningstool; C A Morrison; B D Mosher; P Schneider; P Stevens Journal: Eur J Trauma Emerg Surg Date: 2012-07-12 Impact factor: 3.693
Authors: Roger T Anderson; Tse-Chang Yang; Stephen A Matthews; Fabian Camacho; Teresa Kern; Heath B Mackley; Gretchen Kimmick; Christopher Louis; Eugene Lengerich; Nengliang Yao Journal: Health Serv Res Date: 2013-09-30 Impact factor: 3.402
Authors: Maureen Sanderson; Robert S Levine; Mary K Fadden; Barbara Kilbourne; Maria Pisu; Van Cain; Baqar A Husaini; Michael Langston; Lisa Gittner; Roger Zoorob; George S Rust; Charles H Hennekens Journal: Am J Med Date: 2015-07-11 Impact factor: 4.965
Authors: Jeffrey R Marks; Karen S Anderson; Paul Engstrom; Andrew K Godwin; Laura J Esserman; Gary Longton; Edwin S Iversen; Anu Mathew; Christos Patriotis; Margaret S Pepe Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-12-03 Impact factor: 4.254
Authors: Roger Luckmann; Mary Jo White; Mary E Costanza; Christine F Frisard; Caroline Cranos; Susan Sama; Robert Yood Journal: Transl Behav Med Date: 2017-09 Impact factor: 3.046